Tetragon Partners GP LTD 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Tetragon Partners GP LTD disclosed 32 US equity positions worth $614.3m in its Q2 2026 13F filing. The largest position was PATH at 54.8% of the reported book, followed by KGEI and AUTL. Against the Q1 2026 filing, it opened 5 new positions, added to 15 and reduced 5 among the top 32 holdings.
What did Tetragon Partners GP LTD own in Q2 2026? Top 32 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | PATH UIPATH INC | Technology | 54.8% | $336.4m | 30,950,000 | 23% | added |
| 2 | KGEI KOLIBRI GLOBAL ENERGY INC | 5.5% | $33.8m | 6,834,504 | 0% | held | |
| 3 | AUTL AUTOLUS THERAPEUTICS LTD | Healthcare | 2.5% | $15.2m | 9,500,000 | 0% | held |
| 4 | LYFT LYFT INC | Technology | 2.4% | $14.6m | 1,000,000 | 0% | held |
| 5 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 2.2% | $13.5m | 286,990 | 43% | added |
| 6 | WK WORKIVA INC | Technology | 2.0% | $12.1m | 250,000 | 0% | held |
| 7 | CXM SPRINKLR INC | Technology | 1.8% | $11.4m | 2,200,000 | 0% | held |
| 8 | MBX MBX BIOSCIENCES INC | Healthcare | 1.8% | $11.2m | 203,543 | 40% | added |
| 9 | ALKT ALKAMI TECHNOLOGY INC | Technology | 1.8% | $10.9m | 600,284 | – | new |
| 10 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.8% | $10.8m | 290,441 | -7% | reduced |
| 11 | RLAY RELAY THERAPEUTICS INC | Healthcare | 1.7% | $10.7m | 570,311 | 214% | added |
| 12 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.7% | $10.6m | 130,484 | 3% | added |
| 13 | PHVS PHARVARIS N V | Healthcare | 1.7% | $10.2m | 295,627 | 33% | added |
| 14 | ALKS ALKERMES PLC | Healthcare | 1.6% | $10.0m | 189,979 | 19% | added |
| 15 | IMVT IMMUNOVANT INC | Healthcare | 1.6% | $9.9m | 255,934 | 17% | added |
| 16 | SLN SILENCE THERAPEUTICS PLC | 1.4% | $8.4m | 764,256 | 21% | added | |
| 17 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.3% | $7.9m | 356,657 | 38% | added |
| 18 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.3% | $7.7m | 97,173 | 133% | added |
| 19 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.2% | $7.6m | 205,579 | 25% | added |
| 20 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.2% | $7.3m | 201,036 | 68% | added |
| 21 | KRYS KRYSTAL BIOTECH INC | Healthcare | 1.2% | $7.3m | 19,668 | 0% | held |
| 22 | ANNX ANNEXON INC | Healthcare | 1.2% | $7.1m | 1,242,455 | -4% | reduced |
| 23 | CELC CELCUITY INC | Healthcare | 1.1% | $6.7m | 64,110 | – | new |
| 24 | WBD WARNER BROS DISCOVERY INC | Communication Services | 1.1% | $6.7m | 250,000 | -73% | reduced |
| 25 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.0% | $6.1m | 86,996 | -16% | reduced |
| 26 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.9% | $5.4m | 297,926 | -6% | reduced |
| 27 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.7% | $4.2m | 167,875 | 16% | added |
| 28 | CUE CUE BIOPHARMA INC | 0.5% | $3.0m | 93,819 | – | new | |
| 29 | SNOW SNOWFLAKE INC | Technology | 0.4% | $2.5m | 10,000 | 0% | held |
| 30 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.3% | $2.1m | 400,000 | – | new |
| 31 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.3% | $1.6m | 46,516 | 24% | added |
| 32 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 0.2% | $1.4m | 56,052 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.